Developing and testing a brief clinic-based lung cancer screening decision aid for primary care settings.
Karen Kane McDonnellScott M StrayerErica SercyCallie CampbellDaniela B FriedmanKathleen B CartmellJan M EberthPublished in: Health expectations : an international journal of public participation in health care and health policy (2018)
Evidence supports the value of lung cancer screening with LDCT for select high-risk patients. Guidelines endorse engaging patients and their PCPs in SDM discussions. Our findings suggest that using a brief, interactive, plain-language, culturally sensitive, theory-based DA and SDM strategy is feasible, acceptable and may be essential to effectively translate and sustain the adoption of LDCT screening recommendations into the clinic setting.